Results 91 to 100 of about 4,013 (114)

p300 nucleocytoplasmic shuttling underlies mTORC1 hyperactivation in Hutchinson-Gilford progeria syndrome. [PDF]

Nat Cell Biol
Son SM, Park SJ, Breusegem SY, Larrieu D, Rubinsztein DC.   +4 more
europepmc   +1 more source

Long lifetime and tissue-specific accumulation of lamin A/C in Hutchinson-Gilford progeria syndrome. [PDF]

J Cell Biol
Hasper J, Welle K, Swovick K, Hryhorenko J, Ghaemmaghami S, Buchwalter A.   +5 more
europepmc   +1 more source

The Use of Peripheral Nerve Block and Intra-articular Steroid Injection for Pain Management in an Adolescent with Hutchinson-Gilford Progeria Syndrome: A Case Report. [PDF]

Acta Med Philipp
Endencia MCS, Sy Su KMC, Reyes CRB.
europepmc   +1 more source

Coronary and carotid artery dysfunction and K_V7 overexpression in a mouse model of Hutchinson-Gilford progeria syndrome. [PDF]

Geroscience
Macías Á, Nevado RM, González-Gómez C, Gonzalo P, Andrés-Manzano MJ, Dorado B, Benedicto I, Andrés V.   +7 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

In vivo base editing rescues Hutchinson–Gilford progeria syndrome in mice

Nature, 2021
Luke W Koblan, Michael R Erdos, Christopher Wilson   +2 more
exaly  

Systematic screening identifies therapeutic antisense oligonucleotides for Hutchinson–Gilford progeria syndrome

Nature Medicine, 2021
Leslie B Gordon, Tom Misteli
exaly  

A targeted antisense therapeutic approach for Hutchinson–Gilford progeria syndrome

Nature Medicine, 2021
Michael R Erdos, Wayne A Cabral, Urraca L Tavarez   +2 more
exaly  

Cardiovascular Progerin Suppression and Lamin A Restoration Rescue Hutchinson-Gilford Progeria Syndrome

Circulation, 2021
, Carla Espinós-Estévez, Pilar Gonzalo
exaly  

Development of a CRISPR/Cas9-based therapy for Hutchinson–Gilford progeria syndrome

Nature Medicine, 2019
Olaya Santiago-Fernández, Victor Quesada, Francisco Rodriguez   +2 more
exaly